Abstract

Although fertility naturally declines with age, women who do not wish to become pregnant require contraception until menopause. The safety profile for contraception in women over 40 is different to that of younger women, due to an increased background risk of co-morbidities such as venous thromboembolism, osteoporosis and breast cancer. Conversely, contraception may alleviate or mask symptoms of perimenopause, such as vasomotor symptoms or problematic periods, conferring additional non-contraceptive benefits to women in this age group. For these reasons, the risk-benefit ratio for women over 40 using contraception is different to that of younger women and requires specific consideration when working with women to choose a suitable method of contraception.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.